Israel Gaza war: Latest news from BBC News
<div>Israel Gaza war which started after armed attack by Hamas on 7 October 2023</div>
ChadCowan.com
Meta’s Internal Chip Design Efforts Hit Roadblocks
<div><img src="https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png" style="width: 100%;" /><div>Meta’s Internal Chip Design Efforts Hit Roadblocks - The Information</div></div>
Plug Power sells New York site to Stream Data Centers for $132.5 million
<div><img src="https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png" style="width: 100%;" /><div>Plug Power sells New York site to Stream Data Centers for $132.5 million</div></div>
Buy this pharma stock at current levels, Mizuho
<div><img src="https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png" style="width: 100%;" /><div>Buy this pharma stock at current levels, Mizuho</div></div>
Caesars Entertainment stock surges 18% on takeover interest reports
<div><img src="https://i-invdn-com.investing.com/news/moved_LYNXNPEL901ZY_L.jpg" style="width: 100%;" /><div>Caesars Entertainment stock surges 18% on takeover interest reports</div></div>
Caesars Entertainment halted on circuit breaker following M&A chatter, up 16%
<div><img src="https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png" style="width: 100%;" /><div>Caesars Entertainment halted on circuit breaker following M&A chatter, up 16%</div></div>
ECOENGINEERS, AN LRQA COMPANY, NAMED BEST VERIFICATION COMPANY IN NORTH AMERICA
Environmental Market Rankings by Environmental Finance lists EcoEngineers as Best Verification Company in Three ...
Why This Amsterdam Tech Unicorn Is Betting on Dallas as Its North American HQ
Fresh off a $300 million funding round, hospitality software platform Mews chose Uptown as its first U.S. hub and plans to hire at least 20 employees in the region.
This Food Stock Is the S&P 500’s Top Performer Today. It Needs a Boost.
<div><img src="https://images.barrons.com/im-670654/social" style="width: 100%;" /><div>J.M. Smucker stock rose after the company posted better-than-expected quarterly earnings and revenue.</div></div>
NexPoint: Q4 Earnings Snapshot
<div><img src="https://s.yimg.com/cv/apiv2/cv/apiv2/social/images/yahoo-finance-default-logo.png" style="width: 100%;" /><div>DALLAS (AP) — NexPoint Real Estate Finance, Inc. NREF) on Thursday reported earnings of $23.1 million in its fourth quarter. The Dallas-based company said it had net income of 52 cents per share.</div></div>
Kiniksa price target raised to $53 from $50 at Wedbush
Wedbush analyst David Nierengarten raised the firm’s price target on Kiniksa (KNSA) to $53 from $50 and keeps an Outperform rating on the shares. The firm notes Arcalyst net product revenue of $202.1M in Q4 and $677.6M for FY25 was in line with the pre-announcement and exceeded its prior estimates, reflecting continued expansion in prescriber breadth and depth alongside longer duration of therapy.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter,
Apellis price target lowered to $18 from $20 at Wedbush
Wedbush lowered the firm’s price target on Apellis (APLS) to $18 from $20 and keeps a Neutral rating on the shares. Overall, the Q4 report from Apellis was largely as anticipated with the company preannouncing key results in January, the firm notes. Management anticipates flat Syfovre pricing into FY26 and more limited growth.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana
Oneok price target lowered to $91 from $94 at Stifel
<div><img src="https://s.yimg.com/os/en/tipranks_452/9ea7da3514131adedb82cf60db3762ac" style="width: 100%;" /><div>Stifel lowered the firm’s price target on Oneok (OKE) to $91 from $94 and keeps a Buy rating on the shares. Oneok reported Q4 results in line with expectations and provided 2026 guidance that was below Street expectations and essentially flat with 2025, notes the analyst, who is viewing 2026 as a transition year and anticipates growth resuming in 2027.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market wi</div></div>
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
<div><img src="https://s.yimg.com/os/en/tipranks_452/38a68defd725ddd544390055e985cfb8" style="width: 100%;" /><div>B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $17 from $14 and keeps a Buy rating on the shares. Following BYSANTI’s approval, the firm’s revenue model for Vanda has been updated, reflecting expected growth in the psychiatry franchise with peak BYSANTI sales now included and probability adjustments removed, the analyst tells investors in a research note. Base assumptions include mid-to-high single-digit quarter over quarter growth in BYSANTI/FANAPT prescriptions thro</div></div>
Perfect Corp. Partners with True Beauty Lashes to Launch LashLovr™, a Personalized Lash Recommendation Experience Powered by Virtual Try-On APIs
<div><img src="https://mms.businesswire.com/media/20260226571471/en/2732191/22/Updated_true_beauty_lashes_image.jpg" style="width: 100%;" /><div>Perfect Corp., the global leader in AI and augmented reality (AR) beauty and fashion technology, today announced its partnership with True Beauty Lashes to p...</div></div>
Private-credit managers are betting your money on a market that has never been truly stress-tested
<div><img src="https://images.mktw.net/im-81662511/social" style="width: 100%;" /><div>Retail investors seeking fast cash could trigger a financial crisis.</div></div>
Workday price target lowered to $125 from $250 at DA Davidson
<div><img src="https://s.yimg.com/os/en/tipranks_452/097670a128888e1828116a13ce464258" style="width: 100%;" /><div>DA Davidson analyst Lucky Schreiner lowered the firm’s price target on Workday (WDAY) to $125 from $250 and keeps a Neutral rating on the shares. The company reported just in-line results while providing guidance that missed expectations on both revenue and profitability, and while Workday remains a mission critical system of record, net new demand trends are volatile, the analyst tells investors in a research note. The firm is opting to stay on the sidelines “until organic demand show signs of</div></div>
Obagi Medical, It’s a Secret Med Spa collaborate for ALOHA program
<div><img src="https://s.yimg.com/os/en/tipranks_452/0399b6640bd655b09cf30ff375b3f734" style="width: 100%;" /><div>Obagi Medical announced It’s a Secret Med Spa as a key partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. It’s a Secret Med Spa will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with</div></div>
Latin America’s best- and worst-rated presidents in new poll: Bukele the best, Delcy the worst
El Salvador’s President Nayib Bukele tops a February 2026 regional ranking of Latin American leaders’ public approval, according to a survey by Argentina-based CB Consultora Opinión Pública. Bukele posts 72.6% approval and 24.8% disapproval.
China close to giving Iran a ship-killer as US carriers close in
As US carriers steam toward Iran, China’s CM-302 missile offer could turn a faltering energy-rich partner into a sharper spear in a widening great-power contest over power, data and energy. Reuters recently reported that Iran is close to finalizing a deal to buy Chinese-made CM-302 supersonic anti-ship cruise missiles, according to six people familiar with […]The post China close to giving Iran a ship-killer as US carriers close in appeared first on Asia Times.